SCGE PI Interview: Shengdar Tsai

Поделиться
HTML-код
  • Опубликовано: 14 янв 2025
  • In this interview, SCGE Phase I PI Shengdar Tsai talks about his project, "A novel human T-cell platform to define biological effects of genome editing". Dr. Tsai is an Associate Member in the Department of Hematology at St. Jude Children’s Research Hospital.
    Learn more about Phase 1 projects at scge.mcw.edu/p...
    Learn more about Dr. Tsai's Phase 2 projects at scge.mcw.edu/p... and scge.mcw.edu/p...

Комментарии •